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Abstract:  
Background and Objective: Validation and verification are the critical requirements for the knowledge 
acquisition method of the clinical decision support system (CDSS). After acquiring the medical knowledge 
from diverse sources, the rigorous validation and formal verification process are required before creating the 
final knowledge model. Previously, we have proposed a hybrid knowledge acquisition method with the 
support of a rigorous validation process for acquiring medical knowledge from clinical practice guidelines 
(CPGs) and patient data for the treatment of oral cavity cancer. However, due to lack of formal verification 
process, it involves various inconsistencies in knowledge relevant to the formalism of knowledge, 
conformance to CPGs, quality of knowledge, and complexities of knowledge acquisition artifacts.  
Methods: This paper presents the refined knowledge acquisition (ReKA) method, which uses the Z formal 
verification process. The ReKA method adopts the verification method and explores the mechanism of 
theorem proving using the Z notation. It enhances a hybrid knowledge acquisition method to thwart the 
inconsistencies using formal verification.  
Results: ReKA adds a set of nine additional criteria to be used to have a final valid refined clinical knowledge 
model. These criteria ensure the validity of the final knowledge model concerning formalism of knowledge, 
conformance to GPGs, quality of the knowledge, usage of stringent conditions and treatment plans, and 
inconsistencies possibly resulting from the complexities. Evaluation, using four medical knowledge 
acquisition scenarios, shows that newly added knowledge in CDSS due to the additional criteria by the ReKA 
method always produces a valid knowledge model. The final knowledge model was also evaluated with 1229 
oral cavity patient cases, which outperformed with an accuracy of 72.57% compared to a similar approach 
with an accuracy of 69.7%. Furthermore, the ReKA method identified a set of decision paths (about 47.8%) 
in the existing approach, which results in a final knowledge model with low quality, non-conformed from 
standard CPGs.  
Conclusion: ReKA refined the hybrid knowledge acquisition method by discovering the missing steps in the 
current validation process at the acquisition stage. As a formally proven method, it always yields a valid 
knowledge model having high quality, supporting local practices, and influenced by standard CPGs. 
Furthermore, the final knowledge model obtained from ReKA also preserves the performance – such as the 
accuracy of the individual source knowledge models. 
Keywords: Knowledge acquisition; Clinical practice guidelines; Data driven knowledge acquisition; Cancer 
treatment plan; Clinical decision support system; Formal verification; 
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1. Introduction 
Trust in the knowledge base is a crucial factor in the adoption of clinical decision support systems (CDSS) 
used for medical diagnosis and treatment plan [1]. It mainly depends on the reliability of the knowledge source 
and the consistency of the knowledge acquisition method [2]. There are diverse sources of clinical knowledge, 
such as patient data, clinical practice guidelines (CPGs), clinical trials, systematic reviews, and even social 
media. Various knowledge acquisition approaches have been proposed to acquire clinical knowledge from these 
sources. For example, using machine learning and ontological approaches, knowledge models from patient data 
are created [3–5], and different cognitive approaches are used to develop knowledge models from CPGs and 
other medical resources [6–9]. Depending on the requirements, these knowledge models may need to be 
transformed into different model formats. For example, the knowledge model from CPGs can be converted into 
computer-interpretable guidelines (CIGs) so that it could be directly plugged into CDSS for inferencing. 
Furthermore, sometimes it is required that the knowledge acquisition methods transform two different 
knowledge models (sharing the same domain problem possibly with different sources) into a unified knowledge 
model. It is critical in knowledge engineering disciplines that each transformation, provided by the designed 
knowledge acquisition method, shall ensure the two basic requirements: 
1. The transformed knowledge model is the valid representation of the source knowledge model(s). 
2. The transformation process is consistent enough to produce always a valid knowledge model. 
 
Figure 1 shows the knowledge transformation with a set of knowledge acquisition methods in general. The 
two basic requirements, for each transformation, are depicted as necessary questions to be answered at each 
knowledge acquisition method of transformation. Question 1 reflects the first requirement mentioned above, 
and the answer is to provide a validation mechanism in the knowledge acquisition method. Question 2 represents 
the second requirement of the knowledge acquisition method, which necessitates the verification mechanism in 
the knowledge acquisition method. In a nutshell, validation, and verification are the critical requirements in the 
CDSS development process to ensure that the knowledge model is valid, and the entire knowledge acquisition 
method is consistent.  
In terms of verification, most of the existing approaches [8,10,11] emphasize the principles of knowledge 
engineering. However, none of them have focused on the alignment of the verification process to the 
development processes of CDSS.  On the other hand, formal methods are widely used in software engineering 
disciplines such as verification of program [12], formal modeling for scenario-based requirement specification 
[13], formal verification of secured online registration protocols [14], and formal verification of web services 
on cloud infrastructure [15]. Additionally, some attempts were made to use the formal method (Z notation) to 
express the knowledge base structure and reasoning mechanism in the form of a software architectural style. 
For example, Gamble et al. [16] applied Z notation to formally model the knowledge base to get the clear 
distinction of reusability of knowledge, enhanced understandability, and flexibility of specification in 
comparison to traditional knowledge specification approaches.    
This paper introduces the formal verification process, using Z notation, for our earlier proposed hybrid 
knowledge acquisition method of Smart CDSS [17] – which is intended to produce guideline-enabled data-
driven knowledge model. In hybrid knowledge acquisition, we integrated/supported the method with the 
sophisticated validation process. The knowledge model created for oral cavity cancer was validated based on 
the well-established validation criteria and test-based validation process. However, the knowledge acquisition 
method was not formally verified for internal consistency. The adaption of the formal verification process gives 
an enhanced knowledge acquisition method – which is known as a refined knowledge acquisition (ReKA) 
method. In ReKA, we use the Z notation. The selection of Z notation was mainly based on its key features such 
as data rich formalism, ease in knowledge modeling, and support of tools. It is important to mention here that 
the artifacts of the proposed verification process (using z notation) align to the content of a development 
framework that we have indigenously used for the development of Smart CDSS in the cancer domain. The 
development framework for Smart CDSS is based on RUP [18,19] and ISO RM-ODP processes [20,21]. To the 
best of our knowledge, the existing approaches had neither explored the use of Z notations for the verification 
of knowledge acquisition nor used the formal methods as a method content in a CDSS development framework.  
Before the introduction of the ReKA method, the validity of the knowledge model in the proposed Smart 
CDSS relied solely on the domain experts. They were free to refine the decision paths in the final knowledge 
model. This freedom in refinement leads to a set of inconsistencies. Examples of some possible inconsistencies 
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in terms of clinical context of oral cavity cancer that could be introduced into knowledge model; i) domain 
expert may add inappropriate follow-up treatments to knowledge models – such as treatment surgery followed 
by radiotherapy for palliative patients that is a deviation from CPGs which suggest follow-up without further 
treatment and ii) domain expert may add or refine the rule of evaluating next treatment plan for a variable or 
patient condition that is not readily available or not in use in existing clinical practices – such as evaluating the 
palliative patient for radiotherapy based on histopathological risk factor perineural invasion (PNI). In the scope 
of the current study, this refinement produces inconsistency of introducing non-recordable risk factors 
(outbound refinement as PNI does not exist in the healthcare system).   
This paper addresses following research questions: a) Does the introduction of formal verification using 
Z notation can identify the inconsistencies in the developed knowledge acquisition method concerning standard 
knowledge resources such as CPG?; b) Does formal verification ensures that knowledge acquisition methods 
will always maintain the quality of the knowledge?; c) Does the proposed formal verification can prevent 
inconsistencies occurred due to complexity and freestyle usage of refinement in the knowledge?; d) Is the 
knowledge model created using ReKA superior to existing hybrid knowledge models in terms of validity, 
quality, and integration with workflows? 
The detailed evaluation shows that the introduction of formal verification has significantly contributed to 
revealing hidden inconsistencies in earlier proposed hybrid knowledge acquisition method. In the presence of 
these inconsistencies, the knowledge model evolution is not always guaranteed to be valid. The ReKA method, 
as a result of the verification, can identify the leading cause of the inconsistencies and guarantees always 
producing the valid final knowledge model.  
The main contributions of this work are as follow: 
 Various aspects of Z notation exploited for the knowledge modeling and associated processes are 
expressed as the inferenceable mathematical models. 
 The proofs of the theorem using Z notations provide a comprehensive explanation for checking the 
consistency of the knowledge acquisition method. These proofs enable detection of hidden 
inconsistency in the acquisition method (hybrid knowledge acquisition) and provide an additional set 
of nine criteria to ensure that the enhanced method (ReKA) always produces a valid knowledge 
model. 
 The formal verification activities are streamlined into a particular set of processes that align with 
various artifacts of Z notation. it is worthwhile to 
 
Figure 1: Knowledge acquisition process 
 
2. Overview of knowledge acquisition for Smart CDSS 
In our earlier work, we proposed a novel hybrid knowledge acquisition method for Smart CDSS [17]. The 
acquisition method was accompanied by the proper validation process to ensure the validity of the final 
knowledge model. Before going into details of formal verification, it is worthwhile to briefly introduce the 
knowledge models and validation processes of the hybrid knowledge acquisition method. We encourage the 
readers to read [17] for detailed descriptions of the models and validation processes used in the hybrid 
knowledge acquisition method. 
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2.1. Hybrid knowledge acquisition approach for Guideline enabled data-driven knowledge model 
In the clinical domain, patient data and CPGs are the most common sources of knowledge for CDSS. Most 
of the existing knowledge acquisition methods use both sources of knowledge independently. From patient data, 
the knowledge models are created using machine learning, while from CPGs, various cognitive methods of 
knowledge acquisition apply to the knowledge models. Both methods have potential pros; however, there exist 
some limitations for each of them. The knowledge acquisition method which combines both approaches can 
overcome somehow those limitations. The key limitations of data-driven knowledge acquisition methods using 
machine learning are as follows: 
 The quality of the knowledge model depends on the quality of the patient dataset. Therefore, the 
performance of the model (such as accuracy) may vary for the same domain with different datasets. 
 The model validation relies on the statistical validation process (e.g., 10-fold cross-validation). In this 
case, the validation purely depends on data; and the domain experts are unable to assert any additional 
criteria to apply constraints on the final knowledge model. 
 The final knowledge model supports only local evidence as it is derived from patient data. The 
recommendation becomes trustworthy for another organization if standard evidence from CPGs and 
other published studies also associate with the data-driven knowledge model. 
 
The use of CPGs as a knowledge source somehow resolves the inherent problems with the data-driven 
approach. CPGs covers population-based knowledge supported by standard clinical evidence gathered from 
different clinical studies. Although it overcomes some cons of the data-driven approach, however, the 
knowledge models derived from CPGs also come with at least the following limitations: 
 CPGs are generic, and the model representing CPGs may not be able to integrate into health-care 
work-flows directly.  
 The knowledge model strictly conforming to CPGs discourages local practices. In most cases, it is 
possible that local practices may not fully conform and contradict to CPGs, but may have a 
considerable impact on patient care at that particular region. 
 
Very few studies include CPGs and patient data as a combined source for hybrid knowledge modeling. 
For example, Toussi et al. [22] used a model derived from patient data to complete the missing decisions in the 
CPGs. However, the primary motivation of hybrid knowledge acquisition method is to combine the data-driven 
knowledge acquisition method and CPGs based knowledge acquisition method to dilute their cons and take 
advantages of their pros in terms of the refined knowledge model. This knowledge acquisition method is 
adopted under the umbrella of the three-phase iteration process model of creating an executable knowledge 
model for Smart CDSS [17] in the cancer domain. The first two phases of the process model dedicated to 
knowledge acquisition, which covers knowledge model creations from CPGs and patient data and the validation 
process. The third phase focuses on the executable knowledge model and the development of associated toolset 
[23]. Figure 2 depicts the abstract representation of hybrid knowledge acquisition method, and the next section 
provides a brief description of the core knowledge models and validation process of this approach.  
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Figure 2: Hybrid knowledge acquisition method 
 
2.2. Knowledge models and validation mechanism 
Hybrid knowledge acquisition method includes a set of tasks encompassing two phases of the iterative three-
phase model [17]. In this section, we briefly describe the knowledge models and the process associated with 
the validation of the models (see Figure 2). The outcome of this method is the final knowledge model - known 
as a refined clinical knowledge model (R-CKM), which is obtained after the rigorous validation process. It 
consumes the knowledge models created from CPGs - known as a clinical knowledge model (CKM) and 
prediction model (PM) created from patient data. 
 
Prediction Model: A PM is a decision tree obtained from patient data using decision tree algorithms. The 
decision tree algorithm used for this study was CHAID [24], which was selected based on rigorous selection 
criteria. The selection criteria were based on the consensus of the domain experts, which was intended to create 
a PM with high accuracy and providing a minimal set of decision paths by involving fewer dominant condition 
attributes. These criteria were translated into a quantitative measure using the weighted sum model. As a 
decision tree formalism of the machine learning paradigm - it includes the root node and grows in a top-down 
fashion. The nodes represent conditions and leaf nodes as conclusions. The conclusion always lies at the leaf 
node where the branch selection at each condition uses proper statistical evaluation processes to proceed for the 
appropriate decision path. Finally, performance (such as accuracy) for each decision path evaluates from patient 
data, and its overall performance represents as mean accuracy of all the decision paths in PM. 
 
Clinical Knowledge Model: A CKM is a formal decision tree created from CPGs after a rigorous inspection 
process by a team of physicians. It follows decision tree formalism started with a root node. The tree grows in 
a top-down fashion from the root node by adding subsequent nodes to make a decision path. The nodes represent 
a decision node and a conclusion node. The decision node represents condition(s) (such as patient symptoms) 
to select the next branch of the tree among decision paths. The conclusion node reflects the recommendations 
(such as treatment plan). In CKM, the conclusion node can also play the role of condition node for the next 
follow-up conclusion. For example, an initial treatment plan for cancer patients may be surgery, and after 
follow-up, the secondary treatment plan can be radiotherapy only if surgery is already done. In this context, 
unlike the decision tree formalism of PM, the conclusion node may appear as an intermediate node in the CKM 
decision tree. Moreover, the branch selection of the CKM decision tree does not follow any probabilistic 
evaluation of the condition because CKM is a reference model of CPGs, so its performance evaluation against 
local patient data is not required. 
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Refined Clinical Knowledge Model: A R-CKM obtained after a rigorous validation process by combining PM 
and CKM. It follows the same formalism as of CKM. However, it also reflects some of the properties of PM to 
encourage decision making from local practices. Unlike CKM, all decision paths in R-CKM evaluated from 
local patient data, and it also requires evidence for decision paths that are refined but have no direct conformance 
to the CKM (i.e., guidelines).  
 
Validation Process: A validation process is the core of the hybrid knowledge acquisition method, which unifies 
two different models to a single refined knowledge model. Figure 3 depicts detailed steps of the process. It 
consumes PM and CKM as an input model and produces R-CKM as an output model. Each decision path in 
PM is selected and added to the decision path of R-CKM after passing conformance criteria based on CKM. 
The PM decision path may be refined by domain expert if required. The activities for the validation process 
briefly summarized in three steps: 
 
1. Setting validation criteria: Domain experts define criteria based on CKM (guidelines) and other evidence 
to be fulfilled by the decision path in PM. At the same time, each criterion is classified as primary 
(compulsory) or non-primary (optional with an alternate), and the order of checking specifies by priority. 
In the case of an oral cavity cancer treatment plan, domain experts decided two primary and two non-
primary criteria. i) The minimum performance limit must be satisfied by each selected decision path in 
PM (e.g., an accuracy greater than 50% in this study); ii) the selected decision path in PM must not conflict 
with the CKM (guidelines); iii) the decision path in PM should conform to any decision path in CKM, and 
iv) if criterion iii) is not fulfilled, then the decision path in PM must be associated with an evidence which 
proves its necessity and effectiveness of inclusion into R-CKM.   
  
2. PM validation against criteria: During this step, each decision path is selected and evaluated against the 
well-established criteria. The decision path of PM becomes part of R-CKM if it fulfills the criteria. 
 
3. Inspection and refinement of selected PM decision path: The selected decision path can become directly 
part of R-CKM. However, the domain expert may want to refine it further to reflect the most concrete 
concepts used in the healthcare workflows. Moreover, the refinement process also allows adding further 
choices of the treatment plan in the decision path if required.  
 
Figure 3: Validation Process [17] 
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The hybrid knowledge acquisition method was used in the creation of the knowledge model for Smart 
CDSS in oral cavity cancer [17,23] with proper validation mechanism. However, it was not formally verified 
even after using it as a core method of knowledge acquisition for Smart CDSS. In the validation process at the 
refinement step, the process provides the freedom to domain experts for adding further treatment plans as a 
condition to the selected decision path. It leads toward inconsistency and cannot guarantee the validity of R-
CKM at all times. In order to cope with this issue, the content of this work introduces the verification process 
using formal Z notations. The formal processes are aligned with the existing knowledge acquisition method and 
presented as an enhanced ReKA method. 
 
3. Preliminaries and key motivation of using the formal method for knowledge acquisition 
3.1. Preliminaries 
There are several ways to represent objects in the Z notation. Declaration, abbreviation, and axiomatic 
definitions are simple ways to represent objects in Z notation. "Schema" and "free" types are special ways to 
represent complex objects in Z notation. All these types obey mathematical laws and have rules for reasoning 
with the information that they contain. The important concepts are briefly introduced below. Figure 4 outlines 
all other concepts used in this paper. For a detailed review of these concepts, see [25,26] and other research 
works that have used Z notation extensively [27–29]. 
 
Declaration: This is the simplest way to define an object. When an object is a set of some basic type, 
brackets are used to enclose the name of an object. If there are more than one objects, comma is used for 
separation between them. For example, type definition (1) in Figure 5 represents multiple object declarations. 
ConditionAttribute and ConditionValue are the set of concepts and the corresponding values, respectively, in 
the clinical knowledge model that construct the basic Condition. 
Free type: Free type allows a variety of data structures to be represented using sets with explicit structuring 
information. For example, type definition (3) in Figure 5 highlights three different object definitions. 
ConditionOperator is a free type that distinctly represents the set of operators used in the Condition. The 
Condition further expresses the complex definition of the conditions used in the clinical rules. treatmentSet is a 
free type that covers high-level semantics for cancer treatments that provided to a patient in a proper sequence 
by using the guidelines. 
Axiom: Axiom provides the ability to define objects and includes constraints upon it. In an axiomatic 
definition, the object definition represents in two compartments: declarations and predicates. Declarations 
represent the content structure of an object and predicates introduce constraints on the contents. Figure 6 shows 
an example of the axiomatic definition for CKM specification.  
Schema: Schema is the most powerful artifact in Z notation and describes the system behavior. Similar to 
an axiom, it defines objects using declarations and predicates. However, the schema can take different forms 
such as a modeling static structure, modeling operations, and modeling different states of the object after 
operations. Figure 6 shows an example of modeling CKM as a "ClinicalKnowledgeModel" schema. 
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Figure 4: Z notation concepts overview 
Abbreviation: Abbreviation introduces another name to an existing object. For example, type definition 
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Figure 6: Axiomatic definition and schema example 
3.2. Motivation: Formal methods for Knowledge Verification 
The ability of domain experts to trust knowledge content is a key factor that influences the success of 
CDSS implementation. The trust in knowledge primarily depends on how well the knowledge contents have 
passed through a sophisticated validation process to ensure consistency in the refined knowledge model. 
According to a systematic review by Mor Peleg [2], formal verification techniques are used to validate the 
clinical knowledge for internal consistency and to check for the fulfillment of the desired properties and 
specifications. There are two broad categories of these techniques: model checking and theorem proving [2]. In 
model checking, the knowledge is transformed into an appropriate model-checker format, and the model 
checker verifies the consistency of the knowledge model for the fulfillment of the desired properties. Alessio 
Bottrighi et al. applied the model checking approach to integrating the computerized guideline management 
system [30]. The guideline representation language GLARE is used and integrated with the SPIN model checker 
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to verify the clinical guidelines. Theorem proving uses the logical derivation of theorems in order to prove the 
consistency of the knowledge contents available in the formal specification. Annette T. Teije et al. [31] used 
KIV-based formalism to represent medical protocols and defined semantics of the desired properties. The 
desired properties of the protocol are verified using formal proof of the KIV theorems. 
Based on the substantial advantages and the need for formalism in knowledge validation and verification, 
we introduce the formal verification process as a formal method content into the development framework of 
Smart CDSS. Selection of an appropriate formal method requires formal guidelines to find the best fit for a 
knowledge representation scheme. In this work, we used the Z notation as the formal representation language 
for knowledge representation and for modeling the validation method features. Following are fundamental 
features of Z notation, which compels its suitability for clinical knowledge modeling and verification of the 
acquisition process. 
 
1. Easy knowledge modeling: While using the Z notation, it is simple to decompose the knowledge 
specifications into small pieces and formally define the static and dynamic aspects of the knowledge 
acquisition (i.e., the knowledge representation and validation process [25]). The "Schema" represents this 
aspect of Z notation, where the first-order predicate logic uses the constraints on the typed knowledge 
contents. Moreover, dynamic schema represents the validation process that operates within the boundaries 
of the knowledge representation schema. The subsequent sections will elaborate, detailed contents of the 
formal verification process for the knowledge acquisition method in terms of Z specifications.  
2. Data-rich formalism: Another aspect of Z notation is the notion of "types" [26]. Z types are mathematical 
data types that can be used to represent any object in a system uniquely. They specifically obey a rich 
collection of mathematical laws, which make it possible to determine the behavior of the system [25,26]. 
This aspect of Z leverage, towards data-rich formalism of knowledge contents and the resulting artifacts, 
can be easily mapped to standard viewpoints of RM-ODP [32] (e.g., the information viewpoint). H. 
Bowman et al. used Z notation for consistency checking of the two views in the information viewpoint 
[33]. Similarly, artifacts of Z notation can also map to the "analysis" and "design" disciplines of the RUP 
framework. 
3. Support of tools: The Z specification language not only enables formal specifications for a system and a 
language but also allows for the systematic reduction of such specifications into implementations [27]. 




4.1. Refined Knowledge Acquisition (ReKA) method 
ReKA uses all the steps of hybrid knowledge acquisition described in section 2.1. Besides, it introduces 
new processes that involve the formal verification artifacts at different phases of the three-phase model. Figure 
7 shows the extended three-phase model used by the ReKA method. The extended processes are reflected as an 
additional layer of the underlying processes. 
This study focuses on the newly adopted processes of formal verification, so we skip details of the common 
process used with hybrid knowledge acquisition. The model created for oral cavity cancer in the earlier study 
is reused for this study with new patient cases of 1229 from Shaukat Khanum Memorial Cancer Hospital 
(SKMCH), Lahore, Pakistan. Example scenarios have been created by physicians to modify our earlier oral 
cavity treatment model. Based on the earlier hybrid knowledge acquisition method, the modifications are valid; 
however, as demonstrated in the results section, ReKA identifies that the modifications are not valid because it 
creates inconsistencies in the final knowledge model.  
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Figure 7: Extended three-phase model for ReKA 
 
4.2. Establishing a formal modeling process 
To the best of our knowledge, no substantial evidence exists in a knowledge engineering discipline that 
discusses Z notation with discrete processes having proper guidance. Based on the capabilities of Z notation 
and the guidance available for applying different concepts of Z notation to formal modeling [25,26], we 
formulate a formal modeling process for knowledge acquisition method. It comprises four distinct processes: 
"modeling problem", "defining function and model states", "proving consistency", and "refine specification for 
concrete design". Below is a brief discussion of each of these processes. Figure 8 shows an abstract view of 
these processes. 
 
1. Modeling problem: This includes tasks used to analyze the problem context and identifies all the 
relevant concepts that contribute to the final objectives. Different constructs of the selected formalism 
technique are used to model concepts at different granularity levels. Primitive types, axioms, free 
types, and schema are the candidate constructs in Z notations that assist in modeling the problem 
under consideration. During the knowledge acquisition method, various models were created such as 
PM, CKM, and R-CKM. Different constructs of Z notation were used in representing these models. 
The outcomes of this process produce primitive types, free types, sets of axioms, and sets of the static 
schema, which represents the knowledge models. 
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Figure 8: Formal modeling process 
 
2. Defining functions and models state: This includes tasks to define the behavioral aspects of the system 
under consideration. Defining operations related to the candidate models and associating the 
appropriate state model (as a consequence of the operation on the model) are the main activities of 
this process. Schemas are the central construct in Z and can represent the operations and states of the 
models. For the knowledge acquisition method, operations are defined for the retrieval of contents 
from PM, and CKM models. These operations will not affect changing the state of the corresponding 
models. Different operations define for the R-CKM model in order to validate the candidate decision 
path from PM against the CKM model and to evolve the final R-CKM model. As a result of the 
evolution of the R-CKM model, the corresponding state model is defined to formally represent 
possible changes in the contents of the R-CKM model. 
3. Proving consistency: Identifying inconsistencies in the specifications of the modeled problem is the 
ultimate goal of formal methods. The main task is to make sure that the defined models are consistent 
and have no contradictions with their desired requirements. Moreover, it is desirable to verify that the 
operations defined in various models are consistent and that their outcomes are within the intended 
boundaries of the domain. Z specification provides a well-established way to achieve both goals. The 
first part achieves, to prove the constraint part of the state schema of the model is satisfiable using 
"initialization theorem" - to indicate that an initial state, at least, exists. The second part requires to 
investigate “preconditions" for the candidate operations - that may be calculated from the operational 
schema using the one-point rule. For the knowledge acquisition method, the "initialization theorem" 
proves the satisfiability of the R-CKM state schema. Moreover, "preconditions" investigate for all 
operations that evolve the R-CKM model. 
4. Refining specification for concrete design: The refinement process tends to construct and describe 
another model that complies with the original model of the design but is closer to implementation. 
The refinement process comprises large tasks that are applied in consecutive iterations at the data and 
function levels to ensure that the specifications are free of any uncertainty. These specifications are 
closer than previously modeled specification to executable program code. In order to prove that 
refinements are consistent within themselves and appropriately represent the original design model, 
it is necessary to establish a theory for refinement that includes a set of rules for proving the 
correctness. 
 
In this research work, we exploit the first three processes to model the clinical knowledge and the 
validation process in order to prove that the knowledge acquisition is sufficiently consistent with always 
producing valid final knowledge models. The refinement process is helpful for systems where the outcomes of 
the design are required to be sufficiently close for direct conversion into executable code. This process is 
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included purposefully because our knowledge specification can be easily converted into the executable code if 
we properly exploit the Z refinement mechanism. Furthermore, we are presenting the "Proving consistency" 
step in the results section to emphasize the outcome of the formal verification process. 
4.3. Modeling problem 
The modeling problem investigates the basic concepts used in knowledge acquisition for Smart CDSS. 
The fundamental concepts used in Smart CDSS are PM, CKM, and R-CKM, which represent the clinical 
treatment plan for head and neck cancer. Primitive types, free types, axioms, and schema in Z notation are 
candidate constructs to represent these concepts. 
4.3.1. Primitive types 
Primitive types constitute the basic building blocks of the problem under consideration. In Smart CDSS, 
the concepts relevant to the clinical knowledge, which play a pivotal role in knowledge acquisition and 
validation, are cancer treatments (e.g., chemotherapy, radiotherapy, and surgery), clinical objectives (e.g., 
intervention for a treatment plan), and evidence (e.g., combined chemo-radiotherapy has a significant effect on 
patient survival; a success rate of 92%). These concepts are represented as a set using primitive types (Type 
Definition 1 :line 1). Furthermore, cancer treatment is abbreviated (line 3) as a general treatment to provide 
clarity in further specifications. 
 
 
In order to define the formal representation of the knowledge model, primitive types are needed to capture 
the basic concepts used in the knowledge representation scheme. In Smart CDSS, the knowledge models follow 
decision tree representations where the combination of conditions with logical relationships constitutes the 
decision path. The Condition includes clinical concepts as an attribute with an exact value or a range of value 
sets. For example, a condition in the decision tree test node TreatmentIntent = radical represents a patient 
categorization primarily based on the severity of cancer.  Z primitive types (shown in Type Definition 1 (line 




Moreover, free types in Smart CDSS reflects the semantics of the clinical concepts and provides 
conformance to decision tree representation formalism. For example, treatments provided to patients follow a 
sequence according to standard guidelines and protocols; ChemoInduction follows radiotherapy treatments and 
surgery for radical patients (from CKM). In order to capture these semantics, Type Definition 3 defines two 
free types: TreatmentSet and TreatmentPlan (line 1 and line 2, respectively). 
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In Smart CDSS, the knowledge model typically uses decision tree representation; however, PM is different 
from CKM and R-CKM in terms of the decision path. PM does not include treatments as a condition. To 
distinctly represent this formalism, ConditionCKs (line 3) defines a particular condition as a free type for CKM 
and R-CKM. Similarly, RefinedTreatmentPlan (line 4) represents a refinement in final R-CKM, which dictates 
the addition of a treatment to R-CKM as a type of refinement (indicating the placement of treatment plan at a 
particular position in the decision path). 
4.3.2. Knowledge models 
Clinical knowledge models, such as PM, CKM, and R-CKM, are represented as axioms and schemas. 
Subsequent sections explain the specifications for these models. 
Prediction model specifications: Prediction model specifications cover the properties associated with PM 
by decision tree formalism. Figure 9 shows the PM created (using CHAID decision tree) for oral cavity cancer 
treatment intervention [17] with details of corresponding attributes and their formalism semantics. The PM 
specifications are created using an axiom (Axiom 1) and the PredictionModel schema (Schema 1). The 
axiomatic definition for PM represents the basic constructs of PM using decision tree formalism. Accordingly, 
the decision paths are the main constituents of the decision tree skeleton, where a combination of logically 
related conditions makes a single decision path that has one conclusion. The conditions and conclusion are also 
known as nodes of the decision tree, where the conclusion is always a leaf node. The decision tree obtained 
from the data (using machine-learning approaches) also has accuracy in terms of possessing correctly classified 
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Figure 9: PM for treatment intervention in oral cavity cancer and its formalism (C CRT: Chemo 
Induction followed by chemotherapy; C NOS: Carcinoma NOS; CT S: clinical stage S value; CT T: 
clinical stage T value; HistoDisc: Histology description; RT: radiotherapy; SCC: Small cell carcinoma; 





In Smart CDSS, PM follows decision tree formalism, which is obtained from patient medical records 
where conditions are used to represent patient information (e.g., symptoms, problems (diseases), clinical 
observations, and other demographic information (patient history)) and the conclusion represents the treatment 
plan. Axiom 1 includes declarations for the decision path as a partial function from the condition to the treatment 
plan (line 3). Its accuracy is represented by a total function from the decision path to the accuracy (line 5). The 
decision path conditions are represented as a finite set of the Condition (line 1), and the conclusion represented 
by a finite set of the TreatmentPlan (line 2). In order to reinforce the basic properties of the PM decision path, 
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predicates are used to constrain the defined properties. For example, the PM decision path accuracy must lie 
between 0 and 100 (line 8). For all decision paths, there must exist one conclusion, and the conclusion must be 
a TreatmentPlan (line 11). 
Moreover, for validation purposes, we also associate the evidence (if it exists) with the treatment plan 
recommendation that is provided by the decision path in PM. The evidence is a finite set (line 6), which can 
represent the effectiveness of the treatment plan in given patient cases in terms of the success rate (as a 
percentage). It may also include external evidence from other research works. Therefore, the decision path may 
have evidence represented by a partial function from the decision path to the set of evidence (line 7 and line 
12). 
Prediction model specification is further extended through the PredictionModel schema (Schema 1). PM 
is formally represented as a decision tree that is associated with the clinical objectives using the injective 
function from the decision path to the clinical objectives (lines 1, 3, and 7). The PM is associated with accuracy, 
which is the weighted mean accuracy of all of the decision paths in PM (lines 2, 4, and 8). For simplicity, we 
consider an equal number of patient cases for each decision path; this simplifies the accuracy of PM (line 8). 
Also, PM is a decision tree, which means it must include one root node that must be a condition (lines 5 and 9). 
Clinical knowledge model specifications: Clinical knowledge model specification represents the 
formalism of CKM as an axiom (Axiom 2) and the schema ClinicalKnowledgeModel (Schema 2). CKM is a 
knowledge model that represents clinical guidelines using a decision tree formalism. Figure 10 is reference 
CKM created from clinical guidelines [17]. For the brevity purpose, we are not displaying the pictorial 
representation of the formalism as it shares most of the structure artifacts with the R-CKM and hence Figure 11 




As described in a previous section, unlike PM, the CKM decision path also considers the treatment plan 
as a condition, and the conclusion is always a treatment plan. Therefore, decision path represented by a partial 
function from free type ConditionKMs to the treatment plan with axiomatic definition Axion 2 (line 3). The 
constraint defined by a predicate at Axiom 2 (line 6) reinforces the idea of the CKM decision path that may 
contain treatment plans in condition. Moreover, every decision path must have a starting condition other than a 
treatment plan, which defined by a predicate at Axiom 2 (line 7). Axiom 2 (line 1,4 and 2,5) are representing 
the conditions (decisionPathConditionCKM) and conclusion (ConclusionCKM) of decision path in CKM as 
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The ClinicalKnowledgeModel schema (Schema 2) further extends the CKM semantics. According to the 
definition of CKM, it covers-up the guidelines and follows decision tree formalism. Furthermore, it is associated 
with clinical objectives. For example, CKM (in Smart CDSS) consults NCCN guidelines, and its main objective 
is the provision of standard-based treatment plans for tumors in oral cavities. By using the schema definition 
(Schema 2), the guideline is a total function from the standard decision paths to the clinical objectives (line 2). 
CKM is a set of logically related decision paths in the guidelines that fulfill target clinical objectives (lines 1 
and 4). 
 
Every decision path in CKM must start with a condition (other than a treatment plan), and CKM must 
have only one root condition (line 3) shared by all decision paths. Schema (Schema 2) defines these constraints 
by predicates at (lines 5 and 7). 
In CKM, the treatment plan comes as a condition in one decision path and may act as a conclusion for 
another decision path. In other words, the CKM conclusion may occur in an intermediate node. Schema 2 




Figure 10: CKM for treatment intervention in oral cavity cancer(CI: Chemoinduction; CRT: 
Chemotherapy; CT N: clinical stage N value; CT S: clinical stage S value; CT T: clinical stage T value; 
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ECS: Extracapsular spread; FU: Follow-up; MCT: Multidisciplinary consultation; RT: radiotherapy; 
S: Surgery) [17] 
 
 
Refined clinical knowledge model specifications: Refined clinical knowledge model specifications 
represent R-CKM formalism as an axiom (Axiom 3) and a schema (RefinedClinicalKnowledgeModel, Schema 
3). R-CKM follows the formalism of CKM in that it also uses decision tree representation, which includes 
decision paths that have been formally validated from standard guidelines or possess sufficient evidence to 
prove their effectiveness. Figure 11 shows the R-CKM of a treatment plan for oral cavity cancer [17] with 
precise semantics and formalism. In this respect, the R-CKM decision path modeled (similar to CKM) by a 





As a result of refinements, the decision path of R-CKM may fully not conform to guidelines (CKM). In 
such cases, the evidence is required to justify the effectiveness of the refinements made to the decision path of 
R-CKM. To capture this context, a finite set of Evidences (line 6) is associated with the decision path of R-
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Figure 11: R-CKM for treatment intervention in oral cavity cancer and its formalism (CI: 
Chemoinduction; C NOS: Carcinoma NOS; CRT: Chemotherapy; CT N: clinical stage N value; CT S: 
clinical stage S value; CT T: clinical stage T value; ECS: Extracapsular spread; FU: Follow-up; 
HistoDisc: Histology description; RT: radiotherapy; S: Surgery; SCC: Small cell carcinoma; SqCC: 
Squamous cell carcinoma; TP_Intent: Treatment Plan Intent ) 
 
The predicates defined in Axiom 3 (lines 13, 14) capture the semantics of the decision path in R-CKM; a 
treatment plan can be a condition in the decision path, and the decision path must start with a condition (this 
should not be a treatment plan). 
In addition to CKM formalism, decision paths in R-CKM become a part of the model after passing through 
a formal validation process and refinements (Figure 3). In this respect, the decision path in R-CKM has an 
accuracy represented by a total function from the decision path to the accuracy (line 5). Also, the accuracy of 
the decision path must be a finite value bounded interval [0,100] indicated in line (4,10). An injective function 
represents the refinement in R-CKM, as shown in (line 9, 16), which maps the refined treatment plan (a free 
type, line 4, Type Definition 3) to the PM decision path (line 8). 
The declarations and predicates of schema RefinedClinicalKnowledgModel (Schema 3) are mostly similar 
to those of CKM (Schema 2); both share the same formalism. A total function (line 7) defines the new content 
to support the overall accuracy of R-CKM. The intended accuracy calculated by the weighted mean accuracy 
for all of the decision paths in R-CKM (line 12). 
Moreover, R-CKM is derived from PM and validated against CKM (guidelines); thus, the total function 
defines from the R-CKM decision paths to the intended CKM (line 4), and R-CKM modeled by a finite set of 
related decision paths (line 3) associated with CKM (line 9). Furthermore, a predicate adds to the schema (line 
13), which constrains all of the decision paths; these must be derived from PM and aligned to CKM. Similarly, 
using schema inclusion, PredictionModel (Schema 1) and ClinicalKnowledgeModel (Schema 2) are also 
included (lines 1 and 2) into the RefinedClinicalKnowledgeModel (Schema 3) in order to make the contents of 
PM and CKM available to the R-CKM model. 
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Validation process specifications: Validation process specifications encompass the validation process 
(Figure 3) and adequately represent the validation criteria defined for the final knowledge model - R-CKM (See 
step 1: Setting validation criteria in Section 2.2). The schema PMPathValidation (Schema 4) models the 
underlying semantics of the validation process. It includes schema RefinedClinicalKnowledgeModel (line 1), 
which is used to associate the validation process with R-CKM. It also provides a declaration for the two inputs 
that the validation process is supposed to consume: the PM decision path (line 2) and the minimal accuracy 




The validation criteria defined in the validation process of the knowledge acquisition method reflected by 
predicates in the schema PMPathValidation (lines 4-7). The first two primaries (compulsory) criteria defined 
in the schema by conjunction predicates (lines 4 and 5) and two other criteria represented by disjunction 
predicates (lines 6 and 7). 
4.4. Defining functions and state models 
The main functions of knowledge models are to evolve R-CKM based on the validation of the decision 
path. The only evolving model is R-CKM, so the state model for R-CKM is presented. 
4.4.1. Operations on knowledge models 
Two types of operations defined for the knowledge model. For PM and CKM, only retrieval operations 
are required to represent access to different components of the model. So for as R-CKM is concerned, it requires 
specifications for both retrieval and state change operations. 
Operations for PM and CKM: PM and CKM specification provide a set of operational schema related 
retrieval of various components of the PM and CKM, respectively. For the brevity purpose, we concentrate on 
operational schema related to the evolution of the knowledge model. Retrieval schema for the PM and CKM 
are straight forward, and we shall not discuss it further. 
Operations for R-CKM: R-CKM is the only knowledge model that evolves through proper validation 
processes using PM and CKM. Therefore, in addition to retrieval operations, R-CKM also requires definitions 
for operations that represent the addition of new decision paths into the final model (in the presence of the 
validation criteria). For brevity purposes, we only concentrate on operations that are related to the evolution of 
R-CKM. 
EvolveRCKM (Schema 5) is an operational schema that mainly represents the evolution of the R-CKM 
model. The evolution of R-CKM mainly describes as a two-step process after setting the validation criteria: (1) 
a decision path from PM is evaluated against the validation criteria and (2) the selected decision path is refined 
further (if needed) and added to the R-CKM.  
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Accordingly, EvolveRCKM (Schema 5) is defined as a composite operational schema to reflect these steps. 
This composition is modeled as a combination of two schemas: PMPathValidation (Schema 4) and 
AddPathRCKM (Schema 6).  
To get a clear picture of this process, Figure 12 demonstrates three paths of the PM(Figure 9) in the context 
of the validation process(Figure 3) and produce the R-CKM(Figure 11). The two paths (path 1 and path 2) are 
fulfilling the first two compulsory criteria (having a minimum threshold of accuracy without any conflicts with 
CKM) and passing the criteria regarding conformance to CKM (Figure 10). Path 3 fulfilling the compulsory 
criteria; however, it goes for alternate criterion "Evidence" because of the suggested treatment plan does not 
conform to CKM. In the refinement step, path 2 and path 5 are refined to path 2.1, 2.2, and path 5, respectively. 
So far as path 1 is used without any refinements. 
 
 
Figure 12: A running example of validation and refinement of three decision paths of PM 
 
AddPathRCKM is the main operational schema (Schema 6) that evolves the R-CKM and changes the 
original state of the model (Schema 3: RefinedClinicalKnowledgeModel), which represented by a change state 
in the schema (line 1). In order to understand the complexity of the AddPathRCKM operational schema, we 
divide the declarations and predicates into the following explanatory sections: 
AddPathRCKM is the main operational schema (Schema 6) that evolves the R-CKM and changes the 
original state of the model (Schema 3: RefinedClinicalKnowledgeModel), which represented by a change state 
in the schema (line 1). In order to understand the complexity of the AddPathRCKM operational schema, we 
divide the declarations and predicates into the following explanatory sections: 
 Declaration (Input): The AddPathRCKM schema expects two inputs: a candidate decision path from 
PM (line 2) and the desired treatment plan refinements in the decision path (line 3).  
 Declaration (Output): The final decision path of R-CKM, after refinements, is considered to be an 
output for the schema AddPathRCKM (line 4).  
 Predicates (Pre-conditions): These include a set of predicates (lines 5-12) that must be met before 
any changes are made to the R-CKM model (Schema 3: RefinedClinicalKnowledgeModel). Most of 
these pre-conditions are not known in advance but are calculated using the one-point rule and 
simplification proofs. We shall describe some important pre-conditions, as evaluation results, for the 
formal verification process in Section 5. 




 Predicates (Refinements): The refinement process performed on the candidate decision path of PM 
(line 14), and the modified path (line 15) according to the necessary treatment plan that is mentioned 
by the suggested refinements, provided by an input (line 3).  
 Predicates (Evolution): The R-CKM is evolved with the newly refined decision path. All of the 
relevant components of the RefinedClinicalKnowledgeModel schema are indicated through primed 
statements in the operational schema (lines 16-28). These primed statements primarily represent the 
new change state of the R-CKM model; subsequent sections explain further details. 
4.4.2. Model states for knowledge models 
Modifications are only made to R-CKM upon evolution through the EvolveRCKM (Schema 5) operational 
schema using the combination of schema AddPathRCKM and schema PMPathValidation. PMPathValidation 
(Schema 4) validates a decision path of PM against the validation criteria and makes no change to the R-CKM 
model. Thus, AddPathRCKM (Schema 6) makes refinements to the decision path of PM and adds the refined 
path to R-CKM, which ultimately makes changes to the relevant components of the R-CKM. In this respect, 
the state model of RefinedClinicalKnowledgeModel (Schema 3) reflects changes following the AddPathRCKM 
operational schema. The schema RefinedClinicalKnowledgeModel’ (Schema 7) represents the R-CKM model 
state, which encapsulates all of the relevant statements from R-CKM specifications (Axiom 3 and Schema 3). 
The AddPathRCKM operational schema is invoked in conjunction with PMPathValidation through the 
EvolveRCKM operational schema, and PMPathValidation validates the decision path of PM. The changes made 
to the R-CKM model (RefinedClinicalKnowledgeModel’:  Schema 7) by AddPathRCKM operational schema 
are summarized as follows: 
 




 A new decision path added to R-CKM; this adds new conditions to the set of R-CKM conditions 
((Schema 6: Lines 16 and 17)). These changes represented in the state model (Schema 7) at lines 3, 
5, and 16.  
 New refinements introduced to a set of the R-CKM model, which results in the addition of a PM path 
with the associated refinements (Schema 6: Lines 18 and 19). These states reflected in lines 9, 10, 
and 21 in Schema 7.  
 With the new decision path, the R-CKM model evolved for a new conclusion (Schema 6: Line 20), 
which yields new states in the model properties of RCKMConclusion, as indicated in the state model 
schema at lines 4 and 17.  
 For the new R-CKM path, the accuracy of the path will be associated, and the overall R-CKM 
accuracy is recalculated (Schema 6: Lines 21, 22, and 23). The resulting state changes reflected at 
lines 6, 14, 15, 22, and 26 in the state model schema.  
 Evidence of the PM’s decision path associated with the refined decision path in R-CKM (Schema 6: 
Lines 24 and 25). These changes reflected in lines 7, 8, and 20 in the state model schema.  
 Finally, R-CKM evolved with the addition of a new decision path, and the root condition re-evaluated 
(Schema 6: Lines 26, 27, and 28). These evolutions change the states at multiple statements in the 
state model schema, as indicated in lines 11, 12, 13, 18, 19, 23, 24, 25, 27, and 28. 
5. Results 
This section explains the evaluation of the proposed work using two perspectives. First, it demonstrates 
the theorem proving mechanism to show inconsistencies in the hybrid knowledge acquisition method before 
formal verification. The outcome of the formal verification is presented as an enhanced knowledge acquisition 
method – as the ReKA method. We evaluate the ReKA method (in the context of formal verification) against 
our initial approach and describes its discrepancies using real clinical scenarios. Second, we compare our 
enhanced approach with one of the existing relevant approaches developed by Tossie et al. [22]. 
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5.1. Proving consistency of the knowledge acquisition method 
The creation of the formal specification for clinical knowledge models using abstract data type (i.e., Z 
schema), provides the opportunity of two significant proofs that enable consistency of the knowledge 
acquisition method. The first proof ensures consistency of various clinical domain requirements with the clinical 
knowledge models. The second proof demonstrates that each evolution operation on clinical knowledge models 
is never applied outside its specified domain. Both proofs involve mathematical tasks that lead to the overall 
consistency of the knowledge acquisition method. The first proof is achieved by proving the ‘Initialization 
Theorem.’ The second proof endeavor to investigate the ‘Preconditions’ of each evolution operation defined 
over the clinical knowledge model. 
5.1.1. Consistency proof using the Initialization Theorem 
The Z schema encapsulates different variables and operations to represent the behavior and state of the 
model. The predicate component in the schema represents a state invariant of the model, i.e., enlisting the 
domain requirements that must be true in any valid state. In case of contradiction, the model description 
becomes vacuous, i.e., the desired domain requirements are not fulfilled; therefore, no state exists. To verify 
that this is not the case, and the developed models are of some use, the proof of the ‘Initialization Theorem’ 
ensures that at least one state, i.e., the initial state exists for the model. Supplementary Appendix A provides 
detailed background and proof of the initialization theorem for the R-CKM model.  
5.1.2. R-CKM evolution consistency proof using simplified preconditions and proving the property 
composition 
Investigation of preconditions for an operational schema that evolves the model ensures consistencies of 
the process (i.e., operation) in terms of its applicability within the boundary of the domain model. More 
specifically, it represents a set of states for which the outcome of the operations is adequately defined. 
Supplementary appendices B and C provide detailed steps of the proofs that investigate the precondition of 
operations, i.e., AddPathRCKM (Schema 6), which evolves the R-CKM model. The proofs show a new set of 
pre-condition predicates that were not known in advance. The next section provides a detailed evaluation of the 
newly discovered precondition, which gives birth to an enhanced ReKA method. 
 
5.2. Evaluation: Comparative analysis of ReKA and hybrid knowledge acquisition method 
As a consequence of "Proving consistency" mechanism, the main problem is inconsistencies identified in 
step-3 (selection and refinement of the selected PM decision path) of the validation process in the hybrid 
knowledge acquisition method. The inconsistencies are eliminated by introducing nine additional criteria (see 
Table 1) that are placed after refinements. As an outcome of the formal verification, the enhanced ReKA method 
accommodates the newly discovered criteria. The ReKA criteria cover the broad categories of inconsistencies 
defined below. Each criterion contributes to one or more categories of inconsistencies. 
 
1. Category-1 (Violating formalism of the R-CKM): These inconsistencies occur because of  bypassing the 
construction norms of the R-CKM. This category of inconsistencies makes the final model invalid in terms 
of affecting outcomes of other decision paths. Criteria 1, 2, and 7 ensures avoiding inconsistencies related 
to R-CKM formalism.  
2. Category-2 (Violating conformance to guidelines (CKM)): This category represents refinements, which 
produce inconsistencies in a decision path that does not conform to clinical guidelines without associating 
any additional significant evidences. These criteria were in place during the initial steps of the acquisition 
process (in the hybrid knowledge acquisition method); however, it was not available to ensure the 
conformance after refinements. Criteria 5 and 9 explicitly discuss that each refined path must conform to 
CKM.  
3. Category-3 (Compromising quality of R-CKM): These inconsistencies are related to the quality of R-CKM, 
which are mainly instigating from the refinements to the existing PM decision path without re-evaluation 
on patient data. Criteria 6 defines performance (such as accuracy) associated with each refined decision 
path after evaluating against existing patient data. 
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4. Category-4 (Introducing out-bounded refinements): This category discusses the inconsistencies in decision 
path that comes intentionally or unintentionally by introducing conditions or treatment plans which do not 
exist in the hospital information system or out of the scope of the healthcare provider. Criteria 3 and 4 
dictates that a domain expert must include only appropriate conditions and treatments that exist within the 
boundary of the capacity of the healthcare provider.  
 
 
5. Category-5 (Introducing inconsistencies due to complexities): This category is related to Category-1. 
However, it further covers the inconsistencies that occur due to lack of availability of descriptions for the 
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construction of R-CKM. Criteria 8 is the detailed formal description of how to refine the path in order to 
avoid any inconsistencies. Criteria 1, 2, and 7 of Category-1 also comes under this category. 
 
 
Table 2: ReKA method Vs. earlier hybrid knowledge acquisition method (Knowledge validation 
perspective: All refinements are valid in earlier method) 
 
 
The ReKA method can elaborate on the ambiguous steps in the validation process related to refinements. 
To better understand the impact of the ReKA method, Table 2 discusses four refinement scenarios to the 
decision path by the domain expert ( see Path-2 in Figure 12 ). Each of these scenarios introduces inconsistencies 
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that relate to one or more categories. It is important to note that these refinements are valid according to the 
hybrid knowledge acquisition method. 
 
Figure 13 depicts the enhancements made in the knowledge acquisition method in the validation process. 
Figure. 13a shows the initially proposed hybrid knowledge acquisition method with detailed steps of the 
validation process. The ReKA method, with the suggested improvements due to formal verification, is depicted 




(a) The hybrid acquisition method (Before Formal 
Verification) 
 
(b) The ReKA method (After Formal Verification: 
Highlighted part shows enhancements) 
Figure 13: Comparison of ReKA with earlier hybrid knowledge acquisition method (Process enhancement 
perspective) 
 
 Evolution criteria setting: Any refinement in the decision path suggested by domain expert must be 
evaluated against a set of evolution criteria (specified in Table 1) to avoid inconsistencies as 
mentioned earlier in the R-CKM.  
 Criteria checking: All evolution criteria are compulsory, and a refined decision path in R-CKM must 
fulfill each criterion. Any refinement to decision path which is not fulfilling any of the nine criteria 
lists must not be considered, and the domain expert is prompted for the violation and indicated with 
a  non-valid evolution of the R-CKM model.  
 Evolution of R-CKM: After passing the evolution criteria, the refined decision path becomes part of 
the R-CKM, and the process terminates faithfully. 
 
5.3. Comparison with the existing approach 
One way of combining the traditional data-driven approach and guideline-based approach is to use PM as 
a source and transforming it into the final knowledge model R-CKM after rigorous validation process which 
conforms the transformation from CKM - the guidelines. However, the combination of these approaches can be 
done in another manner - considering CKM as a source and adding the decision paths from PM, which are 
missing in the CKM. In this section, we will discuss one of the existing most relevant approaches [22], which 
lies in the second category and draw a comparative analysis with our approach. In order to know the detailed 
description, Figure 14 shows the high-level steps in both knowledge acquisition approaches. These are given 
the same CKM and PM as an input. The resulting outcome - we called the R-CKM model is different with both 
approaches. 
The main limitations of the existing approach are highlighted in Figure 14, and a detailed discussion is 
provided in Table 3. 
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Figure 14: Demonstration of existing approach vs. proposed approach [22] 
 
 




In a nutshell, the existing approach tends to use the PM as a key source to refine the decision paths in the 
CKM while compromising the quality of the model (missing rigorous validation) and integration to existing 
healthcare workflows. We also applied the existing approach to the SKMCH dataset of 1229 oral cavity cancer 
patients and used the CKM as a reference guideline model (derived for oral cavity NCCN guidelines). In the 
final knowledge model, we identified that 26% of the decision paths were violating the quality criteria of lower 
accuracy (in our case, it should be greater than 50%), 30% of the decision paths were not conformed to 
guidelines, and 9% decision paths were violating multiple criteria, i.e., lower accuracy and non-conformance. 
Overall, 47.8% of decision paths lacked to pass the validation criteria. Figure 15 shows the details of the 
decision tree C5.0 algorithm (which is referred by Toussi et al.) with highlighted decision paths lacking one or 
more validation criteria. 
As described in Table 3, the final model obtained from Toussi et al. approach is not necessarily integrable 
to evaluate its performance against patient data available at a local organization. However, as shown in Figure 
15, the source model for Toussi et al. approach is C5.0, which has an overall accuracy of 69.7% on the SKMCH 
dataset. Even considering the Toussi et al. approach produces the final knowledge integrable to existing 
healthcare workflow, still there exists a chance that overall model accuracy will fall from 69.7% because of its 
generalization. In the case of proposed work, we have a rigorous selection process for choosing the appropriate 
machine learning algorithm and as indicated the CHAID decision tree is a candidate algorithm with an accuracy 
of 71% on a data set of 1229 oral cavity patients (see [17] for details of part of knowledge acquisition related 
to this part). Moreover, the final knowledge model – R-CKM performance is improved to 72.57%, as shown in 
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Figure 16. To conclude, the proposed approach also gives higher performance over Toussi et al. on the local 
SKMCH dataset.  
It is important to note that in Toussi et al. work, the selection of algorithm C5.0 is based on the criteria to 
produce more decision paths to assist in the completion of CPGs. Furthermore, C5.0 is suitable for the dataset 
with a large number of features and having a higher chance of missing data. So, for fair comparison and 
evaluation of ReKA against Toussi et al. work, the C5.0 is applied upon the SKMCH dataset.     
 
 
Figure 15: Comparison of the proposed approach with the existing approach using SKMCH oral cavity 
cancer data [22] 
 
6. Discussion 
6.1. Is verification always required for clinical knowledge modeling? 
Validation and verifications are the key pillars of trust on the domain knowledge. However, the use of 
applying both processes mainly contributes to the criticality and complexity of the clinical knowledge modeling 
method and the final knowledge models. In other words, for less critical and less complex clinical knowledge 
acquisition methods and models, validation alone mainly plays a role in establishing the required level of trust 
in the knowledge. For example, in TNM staging for cancer [34], predefined rules or algorithms and 
deterministic mappings are used for final knowledge modeling. The TNM staging knowledge model does not 
need exhaustive validation. It requires a limited set of validation cases to test the validity of complete 
knowledge.  
In contrast, validation and verification should be in place for the knowledge acquisition method, which 
involves different sources of knowledge with diverse structures and semantics. In this research work, the ReKA 
method involves diverse knowledge sources, i.e., CPGs, decision trees (from patient data), and domain expert 
heuristics (in refinements), where each of them has different nature of structure and semantics. Therefore, the 
only validation could not guarantee that the knowledge model is always valid. The formal verification in the 
ReKA method has introduced the necessarily missing steps in our previously hybrid knowledge acquisition 
method, which originally only relied on the validation process. The outcomes of the ReKA method have been 
evaluated through a set of the real clinical scenarios provided in Table 2.    
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Figure 16: R-CKM results using oral cavity cancer data [R-CKM is implemented as set a of HL7 MLMs 
and the evaluation results drawn are based on the structure of MLMs] 
6.2. What is the overhead of the formal verification process and to what extent the formalism is required? 
Formal verification introduces significant overhead in terms of time and selection of expert resource who 
has sufficient skills to model the domain knowledge mathematically. It is important to note that the applicability 
of the formally verified model is not reduced in terms of efficiency rather delay is expected in the delivery of 
the final knowledge model. Therefore, to tune the trade-off among timelines, cost-effective delivery, and 
producing high-quality knowledge model, the maximum extent of formalism is identified during clinical 
knowledge modeling.  
In ReKA method, the formal verification is involved in the first two phases of modeling of CPGs (CKM), 
decision trees (PM) and final model (R-CKM). In the third phase, R-CKM is converted into standard knowledge 
representation of HL7 MLM (medical logic modules) for executation and sharability. There was a choice of 
applying the formal verification (Z refinements) in the third phase of the transformation of R-CKM to MLMs. 
However, we already demonstrated in [17] that the conversion is straight forward, and the MLMs are easily 
validated against the real patient cases, as shown in Figure 16.    
6.3. Whether validation or semi or less formalism sufficient for consistency of complex knowledge acquisition 
models or methods? 
As discussed earlier, only validation is not enough for complex knowledge acquisition methods or models. 
Similarly, semi or less formal analysis of the knowledge acquisition method does not always guarantee 
consistent and valid knowledge. As an example, Grando et al. have demonstrated that using the formal analysis 
for the expressiveness of CIG languages yields satisfiability of some patterns, which was ignored or not detected 
by the less formal analysis method [35]. 
In the hybrid knowledge acquisition method [17], initially, we relied on a rigorous validation process, the 
partial formalism of the decision tree, and freedom of domain expert to modify the existing knowledge model 
with additional constraints. While using the ReKA method, we have realized that relying upon only the 
validation process and partial formalism support of the decision tree, the final knowledge model is not always 
valid. The ReKA method has highlighted a set of inconsistencies, which includes violation of knowledge 
representation formalism (R-CKM), conformance to CPGs, compromising the quality of the model, outbound 
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refinements in the model, and inconsistencies due to the complexity of the knowledge. Each category of 
inconsistency is demonstrated with real clinical knowledge modeling scenarios, as shown in Table 2.  
6.4. Whether formally verified clinical knowledge models or methods always guarantee consistency 
concerning the essential context of the domain? 
According to Boehm definition, validation is all about, “are we building the right product?” and the 
verification is all about, “are we building the product right?” [36]. In terms of clinical knowledge modeling, we 
can interpret the definition in simple words as: “do we create right knowledge model for the clinical domain 
under consideration?” and “do the method of acquisition is right to reflect all essential context of the clinical 
domain in the creation of knowledge model?”. At this stage, knowing all the essential context of the clinical 
domain is important. The verification process will make sure to find the inconsistencies in the acquisition 
process according to the context provided during the validation process. In conclusion, the formal method 
always guarantees the consistency of the model based on the given domain context. However, if the essential 
context of the domain is missing or wrongly perceived in the design, then formal verification is also not the 
ultimate solution to discover the missing or detect the wrongly perceived knowledge.  
6.5. Do intrinsic properties of the formal method influence overall consistencies of the model? 
The underlying expressive power of the formal method has a relationship with the consistency of models. 
The more expressive a language is, the better ease it provides in representing the models; however, it becomes 
hard to prove the overall consistency of the representative model. This challenge is commonly known as the 
non-decidable expression logic, used as a part of a formal specification for the given model. Z formal language 
is one such expressive language that is based on predicate logic. Predicate logic is intrinsically non-decidable, 
and hence it turns out that Z notation inherits this property as well. 
On the contrary, decidability is considered as one of the key features of Z notation in its standard ISO 
specification [37]. Although the reasons are not explicitly in the specifications; however, one reason is that the 
Z is built on the underlying Zermilu Frankline Set theory[38]. This theory tends to restrict the use of the 
universal set in the core set theory. More precisely, Zermilu Frankline introduced a set of axioms known as 
"ZFC" – C stands for axioms of choice, that replace the naïve set theory with more natural axiomatic set theory. 
It reduces ambiguities coming from intuitions, such as reported in Russell's paradox. In this case, even Z is 
using quantifiers' expression from predicate logic; however, the variables in the quantifiers are bounded to a 
finite set, which can be proved easily. Also, the baseline ZFC bounds Z specification to be provable. Although 
Z is decidable, however, it is highly recommended that one needs to restrict the creation of specification with 
minimal use of quantifiers to keep the proofs simple. 
6.6. What key characteristics make Z superior from the ontological approach for clinical knowledge 
modeling? 
Z and ontologies both tend to represent knowledge formally. Both approaches have their pros and cons 
that have to be assessed before selecting the more appropriate one. This section highlights the aspects of Z that 
resulted in our adoption of this approach compared to ontologies. 
 An intricate knowledge acquisition process is used to acquire the clinical knowledge model. This 
process ensures to produce a non-ambiguous (valid) knowledge model (or artifacts) by involving 
consistent (formally verified) acquisition tasks. Z formalism is rich in the toolset to fulfill the 
requirements of an intricate clinical knowledge acquisition process. In contrast, ontological 
approaches focus on the knowledge model (or artifact) while keep relying on external processes to 
define the additional acquisition tasks.  
 To achieve the goal of clinical objective (of the models), passing through the inspection of raw 
clinical knowledge resources, modeling the intermediate clinical knowledge models, and producing 
the final executable knowledge model, the Z has the potential of identifying inconsistencies at every 
knowledge transformation phase. In contrast, ontological approaches are only concentrating on the 
final executable knowledge model.    
 Z is much more expressive than ontological languages. It is due to the support of extensive 
mathematical toolsets and relationships. Ontological languages come with a spectrum of lower to 
higher expressive power, but the later becomes non-decidable.   
 32 of 49 
 
 Z is human-readable but not fully machine-interpretable; however, Z refinements lead the 
specification very close to the real implementation. The ZML is an XML markup for Z artifacts [39], 
which is used to exchange the Z specification between different toolsets. For example, ZML is 
consumed by the type checker to ensure the syntax, passes it to the tools to convert predicates in the 
schema into a disjunctive normal form, and finally, the test generator uses the outcome (in XML) to 
generate the test cases for each disjunction.    
 
6.7. How easy is it to use Z formalism, and what skills are required by the team for formalism in clinical 
knowledge modeling? 
Formal methods have apparent successes in substantially improving the modeling precision, requirements 
clarity, and verification confidence that enables cost-effective and error-free models. Despite these facts, formal 
methods are still not widely adopted. The crucial obstacles are; learning curve, efforts for integration with 
existing processes, and difficulties in maintenance [40].  Although the learning curve for formal methods is 
higher in comparison to procedural languages, in the real development process, very few resources are required 
in the team to handle artifacts related to formal methods. The other team members are only required to observe 
the outcomes of the formal process and to align the milestones accordingly. One example is the WSDL 2.0 
specification.WSDL 2.0 specification [41] is accompanied by Z specification as informative material to support 
the normative specification. A single team member was responsible for handling the formal specifications and 
sharing the outcome (inconsistencies) in the WSDL 2.0 core specifications with other team members.  
In the ReKA, three team members have worked on the formal specification. One team member was an 
expert in Z notation, the second was having the know-how of Z notation, and the third was an expert in 
ontologies. For internal correctness, the developed specifications were inspected by the formal verification 
team, and the outcomes were shared with other team members, including developers and domain experts. So in 
this work, the Z specification was developed by a single team member, verified by two team members, and the 
outcomes were shared with domain experts and developers without indulging them into the technical details.   
6.8. What is the possibility of the evolution of the final knowledge model to comply with locally emerging 
evidence from local practices? 
The ReKA combines the knowledge from CPGs and patient data (retrospective), and it assumes the change 
in model is made if CPGs are revised or sufficient new data is available. In both cases,  the clinical knowledge 
model is not supposed to change frequently. However, the ReKA does not impose any restrictions on the 
evolution of growing knowledge. The final executable knowledge model in ReKA provides the opportunity to 
cope with the evolution of knowledge and provides support for emerging local evidence in the clinical model. 
The final executable knowledge model is a set of MLMs (HL7 based standard procedural rules), which has been 
thoroughly examined in our patent [42] with the philosophy of case-based reasoning (CBR) methodology. CBR 
based approach provides validation for existing MLMs, and it also revises the knowledge if the domain expert 
modifies the final decision based on newly added patient cases.  This extension brings the CBR mechanism to 
evolve the final knowledge model to comply with emerging local evidence. The extension is not fully 
conformed to ‘belief variations’ based on knowledge acquisition. However, the case base and MLM are revised 
based on the discovery of local evidence; therefore, it has a very close analogy with ‘belief variations’ of the 
agents in terms of conformance with new knowledge discovery.   
6.9. How is ReKA extendable to other domains? 
ReKA is easily extendable to other clinical domains, which rely on established CPGs and medical records. 
The core components of ReKA are underlying knowledge resources CPGs and patient data. At the same time, 
it involves humans in the loop to produce a refined knowledge model. So, the ReKA components are used 
without any change if the underlying semantics of knowledge models remained the same.  
In one of our work, the ReKA is implemented in the cardiovascular domain. The final knowledge model 
outperformed for the diagnosis of heart failure with an overall concordance rate of 98.3% [43]. Moreover, by 
involving the CPGs and domain expert heuristics, a subset processes of ReKA is also demonstrated and 
implemented successfully in thyroid nodule treatment[44]. In both domains, well established CPGs and patient 
 33 of 49 
 
data (or only domain expert heuristics) are used without changing underlying semantics of the models. 
Therefore, formal verification is not required. 
Recently we are extending the ReKA to evaluate subarachnoid hemorrhage stroke CDSS, which is mainly 
caused by the rupture of intracranial aneurysm (also known as brain aneurysm). We already developed CDSS, 
which uses a knowledge graph as an underlying representation model; however, it relies only on patient data as 
knowledge resource [45]. The challenge in developing a brain aneurysm prediction model is the unavailability 
of well established (standard) CPGs and non-crisp rupture risk prediction. Instead of using CPGs, the study 
relies on online published resources (non-standard), and for non-crispy risk prediction, we are combining 
various rule-based and probabilistic models. In such knowledge artifacts formulations, the core processes of 
ReKA are reused; however, the underlying semantics of the final model is changed. Therefore, we are expecting 
to apply formal verification to ensure that the acquisition process is consistent with the newly emerged semantic 
of the rule-based probabilistic model. 
6.10. “Why-Not” always can trust the clinical knowledge model created through a non-verified knowledge 
acquisition process? 
Trust in knowledge is one of the main enablers of CDSS use [1]. It is considered a multidimensional area for 
evaluation, particularly in an ecosystem such as CDSS at its early development phase. So trust in CDSS gives 
the potential for patients to avoid harm from healthcare that is not evidence-based. According to the Trust 
Framework Working Group (TFWG) – a chartered workgroup of the Patient-Centered Clinical Decision 
Support Learning Network, nine trust attributes are associated with the overall ecosystem of CDSS 
development. It includes competency, compliance, consistency, discoverability & accessibility, evidence based, 
feedback & updating, organizational capacity, patient-centeredness, and transparency [46]. These attributes 
target various aspects of trustworthiness associated with knowledge artifacts, actors who develop or use the 
knowledge artifacts, CDSS repositories, and its implementations. The following discussion highlights the 
critical trust attributes (compliance, competency, consistency, and transparency), which may not be adequately 
addressed if a non-verified knowledge acquisition process is adapted for CDSS development.    
 Compliance to standard processes 
CPGs are considered one of the trustworthy sources of clinical evidence. The trust in CPGs comes with a 
standard development process. The most common component of standard CPGs comprises; rigorous and 
transparent processes, properly managed conflict of interests, adequate group composition, strict 
intersectional systematic reviews, highly manageable scope, and reliable external reviewing and maintenance 
[47]. 
 Unlike the CPGs, no standard process exists to develop a clinical knowledge model from diverse resources 
with multiple acquisition methods. In the case of ReKA, the source of clinical evidence is not only the CPGs 
but also patient data to accommodate the local evidence. Currently, it is a norm that machine learning ( AI-
based ) acquisition methods are followed for knowledge acquisition from patient data. From the vast majority 
of stakeholders from healthcare – more specifically, the domain experts have no confidence in adapting the 
AI-based clinical knowledge models. Their critical demands from the AI community are in providing and 
establishing a firm foundation of trust in their acquisition methods' validity, consistency, objectivity, and 
reliability [48]. The ReKA is developed indigenously with support of making all knowledge artifacts (AI-
models – PM, CPG-based models – CKM, and combined-models – R-CKM) explicit and traceable through 
formal specifications. The method is equipped with a firm theorem proving mechanism and driven by clear 
clinical objectives to establish a trust in the consistency, transparency, and reliability of the overall 
acquisition process. In the absence of formal verification, most of the upper mentioned concerns yield a lack 
of trust in using the knowledge models. The fact about these concerns has been revealed in the refinement 
process of knowledge acquisition through formal verification. The knowledge produced with hybrid 
knowledge acquisition (before ReKA) should not be trusted because of its non-alignment and conformance 
to a standard process. This led us to find an answer to “Why-Not” so that stakeholders shall trust the 
knowledge produced with ReKA. The ReKA formal verification ensures consistency and identifies all 
hotspots of concerns leading to untrustworthiness. Table 2 provides a couple of scenarios that cover-up the 
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potential of formal verification and answering the “why not” that ReKA is capable of producing a trustable 
knowledge model even it does not fully conform to standard processes.      
 Competence and experiences of domain experts 
Expertise in the domain and capability of the domain expert to create a clinical knowledge model is 
considered one of the important factors of trust in knowledge. According to the study [1], the reason for the 
slower adoption of CDSS by general practitioners was the lack of confidence in the acquisition methods and 
contents of the knowledge, i.e., the expertise of people who created the knowledge base in terms of contents 
and the acquisition process toolsets. The workgroup TFWG also recognizes the influence of expertise of 
domain knowledge experts in the creation of knowledge, and trust attribute 'Competency' is associated with 
knowledge artifacts ensuring trust in the knowledge [46]. The competency dictates the role of the actor (a 
domain expert) to be competent in the CDSS ecosystem. The competency factors can be recognized by 
investigating past performance, professional qualifications, or certifications of the domain expert. More 
precisely, the domain expert should be competent in the knowledge management life cycle, competently 
interpret, encode, and execute the knowledge [46]. Unfortunately, the era is still far away from this idealistic 
situation where every domain expert will be competent enough to set up the same level of trust for the 
creation of knowledge. The most common reasons include; insufficient informatics training programs for the 
domain experts to translate the evidence into CDSS knowledge artifacts, low literacy of domain experts in 
the domain of underlying CDSS technology, and hard to manage the timing for the creation of knowledge – 
they are involved most of the time with patients at clinics [49]. Besides these facts, there are ways to create 
astute knowledge artifacts that may establish a sufficient level of trust.  Firstly, the provision of a knowledge 
development framework which provides room to accommodate and facilitate the collaboration of 
stakeholders with a diverse background and different competencies. Secondly, the provision of the 
knowledge acquisition process that facilitates all stakeholders and evades any loophole in the acquisition that 
leads to the creation of inconsistent knowledge artifact – possibly caused by the stakeholders with low-level 
competency or by other well-known mistakes.  
The ReKA is used under the umbrella of a Smart CDSS development framework that provides a collaborative 
environment for the creation of clinical knowledge models. Furthermore, the formal verification processes 
in ReKA always ensure the creation of consistent knowledge artifacts. “Why-not”, always a valid knowledge 
model is expected in the presence of a non-verified hybrid knowledge acquisition process (before ReKA) – 
because it comes with free refinement process that leads towards easily exploitable loopholes in the creation 
of knowledge models. The low competent domain expert may cause inconsistent knowledge due to less 
knowledge in a domain or by mistake. Considering the scenario 1 in Table 2; it reflects the violation of 
knowledge artifacts by non-conformance to CPGs. Moreover, scenario 2 in Table 2 reflects the violation of 
building proper knowledge artifacts. The first violation possibly caused by domain expert having less 
experience with evidence based knowledge, and the second violation most probably caused by a domain 
expert with less expertise of the toolset and knowledge artifacts. The ReKA facilitates in these cases to 
restrict the stakeholders from creating any knowledge artifact, which reduces trust in overall knowledge 
models.   
 Transparent and consistent knowledge acquisition process and knowledge models 
The promises of AI is undeniable in many domains. There is a race in the research community for setting 
down a record high accuracy benchmark through the new acquisition model. However, the domain of 
healthcare demands from AI-based knowledge models the more equitable humanistic care, not just more 
accurate, scientific care [50]. The black-box approaches are unacceptable as CDSS requires transparency so 
that the user can trace the basis of recommendations that are offered [51]. The knowledge model (acquired 
through black-box) that does not explain the source or nature of recommendations erodes the trust [52]. The 
knowledge acquisition processes are not traceable to be consistent over a set of different patient cases. 
Furthermore, non-transparent knowledge recommendations may weaken the trust relationship between the 
domain expert and patients. The most transparent and consistent knowledge acquisition process and 
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knowledge model may lead to a high level of trust in the recommendations. The ReKA produces knowledge 
models that are conformed to standard CPGs (evidence supportable), and at the same time, only white-box 
approaches (such as decision trees and production rules) are used for acquiring knowledge from patient data. 
Moreover, to keep the models and acquisition process more explicit (traceable, transparent, and consistent), 
the formal verification provided detailed specifications. In conclusion, ReKA uses formal verification to 
justify the “Why-Not” answer, that non-verified properties of knowledge are not transparent, possibly not 
consistent, and not traceable, which ultimately ends up with untrustworthiness. Scenario 4 in Table 2 explains 
how a single refinement in knowledge artifacts triggers a set of inconsistencies that yields an invalid 
knowledge model due to non-transparent and non-traceable hybrid acquisition process (before ReKA). 
7. Conclusion 
This paper has introduced an enhanced ReKA method which performs formal verification using Z 
notation. Z notation proves the consistency of the acquisition process and hence, improves the hybrid knowledge 
acquisition method. The ReKA method is established based on the three steps formal verification process to 
represent the knowledge models formally. Also, it involves the associated validation process of hybrid 
knowledge acquisition using various artifacts of Z notation. Subsequently, the mechanism of theorem proving 
in formal verification has identified inconsistencies in the previously established knowledge acquisition by 
introducing nine additional criteria. These criteria address the broad categories of inconsistencies related to the 
formalism of knowledge, conformance to CPGs, quality of knowledge, and complexities of knowledge 
acquisition artifacts. The ReKA method produces a guideline-enabled data-driven knowledge model that 
supports the high-quality recommendation, global evidence, local practices, and always consistent model 
compared to existing hybrid knowledge models. It is important to mention that the key advantages of the ReKA 
method include its generality, which can be easily adapted in other cancer domains. Moreover, to the best of 
our knowledge, this is the first attempt to use Z notation in the modeling of medical knowledge and to align its 
core step as contents of method plugin, in the Smart CDSS development framework. 
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Supplementary Appendices 
Supplementary Appendix A. Initialization Theorem and proof for R-CKM domain consistency 
The initialization theorem provides a mechanism to prove that the model (R-CKM) is consistent and 
fulfills the requirements. It determines the model has at least an initial state. Definition 1 defines the 
initialization theorem. 
 
For the R-CKM model represented in the schema RefinedClinicalKnowledgeModel (Schema 3), the initial 




For the given initial state InitRCKM of the R-CKM model’s schema RefinedClinicalKnowledgeModel, the 





The proof of this initialization theorem leads to consistent specifications for the R-CKM model. It is almost 
impossible to prove the initial state of the modeling specifications, which include contradictions. Hence, it can 
conclude that the model does not fulfill the desired requirements. 
In order to prove the initialization theorem, we can take advantage of the one-point rule as well as some 
other set theory laws and fundamental definitions. The one-point rule helps to replace the existential quantifier 
when the bound variable has an identity within the boundaries of the quantification expression. For the one-
point rule, Definition 2 provides the essential background related to replacing the existential quantifier. 
Following the definition of the one-point rule, and other fundamental laws and definitions, the proof of 
initialization theorem is given in Proof 1. The proof is straightforward, and each step is explained with 
instructive definitions. 
 







 42 of 49 
 
Supplementary Appendix B. Calculating pre-conditions for R-CKM evolution 
The precondition of operation is another schema, obtained from a given operation, that hides components 
related to the state after the operation and provides an output that results from an operation. 
We establish a theorem (Theorem 2), which is based on the basic definition of the pre-condition schema 
(Definition 3), to calculate the pre-conditions for the operational schema AddPathRCKM (Schema 6). 
 
Calculation of pre-condition requires simplification of the predicate part of the theorem (Theorem 2), which 
involves the expansion of all schemas. After the expansion of all possible schemas, the one-point rule plays a 
pivotal role in simplifying and proving the primed statements in the schema. Due to space limits, the proof is 
provided as supplementary appendices. The Supplementary Appendix A explains the proof with instructive 
definitions at each evolving step of the schema. For brevity purposes, the proof does not discuss the pre-
condition calculation in detail; however, we believe that the given explanation is sufficient to determine the pre-




Although the simplification process seems quite complicated in terms of resolving all of the primed 
statements, however using set theory fundamental laws and the one-point rule, it becomes straightforward. The 
primed predicates in Proof 2 are underlined (numbered 1-13). The prime predicates require simplifications to 
conclude the proof. To save space, the Supplementary Appendix C presents the simplification proofs. 
 












Supplementary Appendix C. Simplification of primed statements using logical proof 
This section describes the detailed steps used to prove the primed statements in Proof 2 (line 2.42 to 2.54). 
The primed statements are evolved using fundamental laws of set theory and deduction rules to obtain the 
simplified form. All proofs (Proof 5 - 15) are straightforward, and instructions are provided for each logical 
statement.  
We introduce the necessary definitions (if required) before each proof in order to clarify the logical steps 
in the corresponding and subsequent proofs. Proof 3 provides the simplification of the first prime statement in 
Proof 2 (line 2.42), which is concluded to the simplified statement of the R-CKM model ((Axiom 3: line 11). 
In addition to the one-point rule (Definition 2), the following basic definitions (Definitions 4, 5) are used to 
deduce the final conclusion.  
Proof 4 simplifies the primed statement in Proof 2 (line 2.43) to the refined statement of the R-CKM model 
(Axiom 3: line 12). Using the one-point rule (line 4.02), set subtraction, and ran properties (line 4.03- 4.05), 
the proof is easily concluded. The ran property for the union is defined as follows. 




Proof 5 simplifies the primed statement in Proof 2 (line 2.44) using the one-point rule (line 5.02), the 
definition of range (line 5.03 using Definition 6), and other laws and principles of set theory, which are 




Using the one-point rule (line 6.01) and definitions of basic set theory (lines 6.02 - 6.04), Proof 6 concludes 
the primed statement in Proof 2 (line 2.45) into the R-CKM model (Axiom 3: line 14). 
Proof 7 concludes the primed statement in Proof 2 (line 2.46) into the R-CKM model (Axiom 3: line 15) 
using the one-point rule (line 7.02) and definitions of basic set theory (lines 7.03 - 7.05). 
Using the one-point rule (line 8.02) and definitions of basic set theory (lines 8.03 - 8.05), Proof 8 concludes 
the primed statement in Proof 2 (line 2.47) into the R-CKM model (Axiom 3: line 16). 
Proof 9 concludes the primed statement in Proof 2 (line 2.48) into the R-CKM model (Schema 3: line 8). 
This proof is straightforward, and its conclusion is reached by using the one-point rule (line 9.02, 9.09) and 
solving the inequalities with fundamental mathematics. The proof is logically decomposed into two parts (lines 
9.03-9.07 and lines 9.08-9.11). Each part is proven separately, and the final statement is concluded (line 9.12). 
 






The remaining proofs (Proof 10-Proof 15) use the same pattern of logical proofs to simplify the remaining 
primed statements of Proof 2 (line 2.49-line 2.54). Each step in the proofs is provided with instructive 
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